[1]
Piano, M.R. Cannabis smoking and cardiovascular health: It’s complicated. Clin. Pharmacol. Ther., 2017, 102(2), 191-193.
[3]
Hall, W.; Solowij, N. Adverse effects of cannabis. Lancet, 1998, 352(9140), 1611-1616.
[4]
Volkow, N.D.; Baler, R.D.; Compton, W.M.; Weiss, S.R. Adverse health effects of marijuana use. N. Engl. J. Med., 2014, 370(23), 2219-2227.
[5]
Thomas, G.; Kloner, R.A.; Rezkalla, S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: What cardiologists need to know. Am. J. Cardiol., 2014, 113(1), 187-190.
[6]
Rodondi, N.; Pletcher, M.J.; Liu, K.; Hulley, S.B.; Sidney, S. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am. J. Cardiol., 2006, 98(4), 478-484.
[7]
Jouanjus, E.; Lapeyre-Mestre, M.; Micallef, J. Cannabis use: Signal of increasing risk of serious cardiovascular disorders. J. Am. Heart Assoc., 2014, 3(2)e000638
[8]
Jouanjus, E.; Raymond, V.; Lapeyre-Mestre, M.; Wolff, V. What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review. Curr. Atheroscler. Rep., 2017, 19(6), 26.
[10]
Ashton, C.H. Pharmacology and effects of cannabis: A brief review. Br. J. Psychiatry, 2001, 178, 101-106.
[11]
Kunos, G.; Jarai, Z.; Batkai, S.; Goparaju, S.K.; Ishac, E.J.; Liu, J.; Wang, L.; Wagner, J.A. Endocannabinoids as cardiovascular modulators. Chem. Phys. Lipids, 2000, 108(1-2), 159-168.
[12]
Chen, D.J.; Gao, M.; Gao, F.F.; Su, Q.X.; Wu, J. Brain cannabinoid receptor 2: Expression, function and modulation. Acta Pharmacol. Sin., 2017, 38(3), 312-316.
[13]
Jiang, L.S.; Pu, J.; Han, Z.H.; Hu, L.H.; He, B. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. Cardiovasc. Res., 2009, 81(4), 805-813.
[14]
Singla, S.; Sachdeva, R.; Mehta, J.L. Cannabinoids and atherosclerotic coronary heart disease. Clin. Cardiol., 2012, 35(6), 329-335.
[15]
Sugamura, K.; Sugiyama, S.; Nozaki, T.; Matsuzawa, Y.; Izumiya, Y.; Miyata, K.; Nakayama, M.; Kaikita, K.; Obata, T.; Takeya, M.; Ogawa, H. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation, 2009, 119(1), 28-36.
[16]
Zhao, Y.; Liu, Y.; Zhang, W.; Xue, J.; Wu, Y.Z.; Xu, W.; Liang, X.; Chen, T.; Kishimoto, C.; Yuan, Z. WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice. Eur. J. Pharmacol., 2010, 649(1-3), 285-292.
[17]
Nissen, S.E.; Nicholls, S.J.; Wolski, K.; Rodes-Cabau, J.; Cannon, C.P.; Deanfield, J.E.; Despres, J.P.; Kastelein, J.J.; Steinhubl, S.R.; Kapadia, S.; Yasin, M.; Ruzyllo, W.; Gaudin, C.; Job, B.; Hu, B.; Bhatt, D.L.; Lincoff, A.M.; Tuzcu, E.M. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: The STRADIVARIUS randomized controlled trial. JAMA, 2008, 299(13), 1547-1560.
[18]
O’Leary, D.H.; Reuwer, A.Q.; Nissen, S.E.; Despres, J.P.; Deanfield, J.E.; Brown, M.W.; Zhou, R.; Zabbatino, S.M.; Job, B.; Kastelein, J.J.; Visseren, F.L. Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: The AUDITOR trial. Heart, 2011, 97(14), 1143-1150.
[19]
Tai, S.; Fantegrossi, W.E. Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites. Curr. Top. Behav. Neurosci., 2017, 32, 249-262.
[20]
Servoss, S.J.; Januzzi, J.L.; Muller, J.E. Triggers of acute coronary syndromes. Prog. Cardiovasc. Dis., 2002, 44(5), 369-380.
[21]
Lindsay, A.C.; Foale, R.A.; Warren, O.; Henry, J.A. Cannabis as a precipitant of cardiovascular emergencies. Int. J. Cardiol., 2005, 104(2), 230-232.
[22]
Aryana, A.; Williams, M.A. Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty? Int. J. Cardiol., 2007, 118(2), 141-144.
[23]
Jehangir, W.; Stanton, M.; Khan, R.; Sahgal, P.; Yousif, A. Did cannabis precipitate an stemi in a young woman? Cardiol. Res., 2015, 6(3), 283-285.
[24]
Nawrot, T.S.; Perez, L.; Kunzli, N.; Munters, E.; Nemery, B. Public health importance of triggers of myocardial infarction: A comparative risk assessment. Lancet, 2011, 377(9767), 732-740.
[25]
Mittleman, M.A.; Lewis, R.A.; Maclure, M.; Sherwood, J.B.; Muller, J.E. Triggering myocardial infarction by marijuana. Circulation, 2001, 103(23), 2805-2809.
[26]
Draz, E.I.; Oreby, M.M.; Elsheikh, E.A.; Khedr, L.A.; Atlam, S.A. Marijuana use in acute coronary syndromes. Am. J. Drug Alcohol Abuse, 2017, 43(5), 576-582.
[27]
Desai, R.; Patel, U.; Sharma, S.; Amin, P.; Bhuva, R.; Patel, M.S.; Sharma, N.; Shah, M.; Patel, S.; Savani, S.; Batra, N.; Kumar, G. Recreational marijuana use and acute myocardial infarction: Insights from nationwide inpatient sample in the united states. Cureus, 2017, 9(11)e1816
[28]
Tatli, E.; Yilmaztepe, M.; Altun, G.; Altun, A. Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man. Int. J. Cardiol., 2007, 120(3), 420-422.
[29]
Hamdan, R. Cannabis related coronary thrombosis confirmed by optical coherence tomography. J. Clin. Case Rep., 2014, 4, 7.
[30]
Dahdouh, Z.; Roule, V.; Lognone, T.; Sabatier, R.; Grollier, G. Cannabis and coronary thrombosis: What is the role of platelets? Platelets, 2012, 23(3), 243-245.
[31]
De Angelis, V.; Koekman, A.C.; Weeterings, C.; Roest, M.; de Groot, P.G.; Herczenik, E.; Maas, C. Endocannabinoids control platelet activation and limit aggregate formation under flow. PLoS One, 2014, 9(9)e108282
[32]
Levy, R.; Schurr, A.; Nathan, I.; Dvilanski, A.; Livne, A. Impairment of ADP-induced platelet aggregation by hashish components. Thromb. Haemost., 1976, 36(3), 634-640.
[33]
Cappelli, F.; Lazzeri, C.; Gensini, G.F.; Valente, S. Cannabis: A trigger for acute myocardial infarction? A case report. J. Cardiovasc. Med. (Hagerstown), 2008, 9(7), 725-728.
[34]
Bailly, C.; Merceron, O.; Hammoudi, N.; Dorent, R.; Michel, P.L. Cannabis induced acute coronary syndrome in a young female. Int. J. Cardiol., 2010, 143(1), e4-e6.
[35]
Kocabay, G.; Yildiz, M.; Duran, N.E.; Ozkan, M. Acute inferior myocardial infarction due to cannabis smoking in a young man. J. Cardiovasc. Med. (Hagerstown), 2009, 10(9), 669-670.
[36]
Deusch, E.; Kress, H.G.; Kraft, B.; Kozek-Langenecker, S.A. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth. Analg., 2004, 99(4), 1127-1130.
[37]
Safaa, A.M.; Markham, R.; Jayasinghe, R. Marijuana-induced recurrent acute coronary syndrome with normal coronary angiograms. Drug Alcohol Rev., 2012, 31(1), 91-94.
[38]
Casier, I.; Vanduynhoven, P.; Haine, S.; Vrints, C.; Jorens, P.G. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol., 2014, 69(2), 131-136.
[39]
Rezkalla, S.H.; Sharma, P.; Kloner, R.A. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann. Emerg. Med., 2003, 42(3), 365-369.
[40]
Mukamal, K.J.; Maclure, M.; Muller, J.E.; Mittleman, M.A. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am. Heart J., 2008, 155(3), 465-470.
[41]
Frost, L.; Mostofsky, E.; Rosenbloom, J.I.; Mukamal, K.J.; Mittleman, M.A. Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am. Heart J., 2013, 165(2), 170-175.
[42]
DeFilippis, E.M.; Singh, A.; Divakaran, S.; Gupta, A.; Collins, B.L.; Biery, D.; Qamar, A.; Fatima, A.; Ramsis, M.; Pipilas, D.; Rajabi, R.; Eng, M.; Hainer, J.; Klein, J.; Januzzi, J.L.; Nasir, K.; Di Carli, M.F.; Bhatt, D.L.; Blankstein, R. Cocaine and marijuana use among young adults presenting with myocardial infarction: The partners young-mi registry. J. Am. Coll. Cardiol., 2018, 71(22), 2540-2551.
[43]
Reece, A.S.; Norman, A.; Hulse, G.K. Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: A longitudinal study. BMJ Open, 2016, 6(11)e011891
[44]
Steffens, S.; Veillard, N.R.; Arnaud, C.; Pelli, G.; Burger, F.; Staub, C.; Karsak, M.; Zimmer, A.; Frossard, J.L.; Mach, F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature, 2005, 434(7034), 782-786.
[45]
Jayanthi, S.; Buie, S.; Moore, S.; Herning, R.I.; Better, W.; Wilson, N.M.; Contoreggi, C.; Cadet, J.L. Heavy marijuana users show increased serum apolipoprotein C-III levels: Evidence from proteomic analyses. Mol. Psychiatry, 2010, 15(1), 101-112.
[46]
Franz, C.A.; Frishman, W.H. Marijuana use and cardiovascular disease. Cardiol. Rev., 2016, 24(4), 158-162.
[47]
Ting, J.Y. Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult. Clin. Toxicol. (Phila.), 2007, 45(4), 432-434.
[48]
Kaushik, M.; Alla, V.M.; Madan, R.; Arouni, A.J.; Mohiuddin, S.M. Recurrent stress cardiomyopathy with variable regional involvement: Insights into etiopathogenetic mechanisms. Circulation, 2011, 124(22), e556-e557.
[49]
Nogi, M.; Fergusson, D.; Chiaco, J.M. Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report. Hawaii J. Med. Public Health, 2014, 73(4), 115-118.
[50]
Del Buono, M.G.; O’Quinn, M.P.; Garcia, P.; Gerszten, E.; Roberts, C.; Moeller, F.G.; Abbate, A. Cardiac arrest due to ventricular fibrillation in a 23-year-old woman with broken heart syndrome. Cardiovasc. Pathol., 2017, 30, 78-81.
[51]
Korantzopoulos, P.; Liu, T.; Papaioannides, D.; Li, G.; Goudevenos, J.A. Atrial fibrillation and marijuana smoking. Int. J. Clin. Pract., 2008, 62(2), 308-313.
[52]
Krishnamoorthy, S.; Lip, G.Y.; Lane, D.A. Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: A case series and literature review. Am. J. Med., 2009, 122(9), 851-856.e853.
[53]
Kosior, D.A.; Filipiak, K.J.; Stolarz, P.; Opolski, G. Paroxysmal atrial fibrillation following marijuana intoxication: A two-case report of possible association. Int. J. Cardiol., 2001, 78(2), 183-184.
[54]
Singh, D.; Huntwork, M.; Shetty, V.; Sequeira, G.; Akingbola, O. Prolonged atrial fibrillation precipitated by new-onset seizures and marijuana abuse. Pediatrics, 2014, 133(2), e443-e446.
[55]
Korantzopoulos, P. Marijuana smoking is associated with atrial fibrillation. Am. J. Cardiol., 2014, 113(6), 1085-1086.
[56]
Fisher, B.A.; Ghuran, A.; Vadamalai, V.; Antonios, T.F. Cardiovascular complications induced by cannabis smoking: A case report and review of the literature. Emerg. Med. J., 2005, 22(9), 679-680.
[57]
Bachs, L.; Morland, H. Acute cardiovascular fatalities following cannabis use. Forensic Sci. Int., 2001, 124(2-3), 200-203.
[58]
Montisci, M.; Thiene, G.; Ferrara, S.D.; Basso, C. Cannabis and cocaine: A lethal cocktail triggering coronary sudden death. Cardiovasc. Pathol., 2008, 17(5), 344-346.
[59]
Hartung, B.; Kauferstein, S.; Ritz-Timme, S.; Daldrup, T. Sudden unexpected death under acute influence of cannabis. Forensic Sci. Int., 2014, 237, e11-e13.
[60]
Orsini, J.; Blaak, C.; Rajayer, S.; Gurung, V.; Tam, E.; Morante, J.; Shamian, B.; Malik, R. Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana consumption. J. Community Hosp. Intern. Med. Perspect., 2016, 6(4), 31695.
[61]
Davis, C.; Boddington, D. Teenage cardiac arrest following abuse of synthetic cannabis. Heart Lung Circ., 2015, 24(10), e162-e163.
[62]
Pratap, B.; Korniyenko, A. Toxic effects of marijuana on the cardiovascular system. Cardiovasc. Toxicol., 2012, 12(2), 143-148.
[63]
Alonso, J.V.; Teo, B.H.; Pozo, F.J.; Aguayo, M.A.; Sanchez, A. Brugada electrocardiogram pattern induced by cannabis; Is cannabis
safe? Am. J. Emerg. Med, 2016, 34(8), 1738.e1731-1734.
[64]
Diffley, M.; Armenian, P.; Gerona, R.; Reinhartz, O.; Avasarala, K. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest. Crit. Care Med., 2012, 40(7), 2223-2226.
[65]
Menahem, S. Cardiac asystole following cannabis (marijuana) usage-additional mechanism for sudden death? Forensic Sci. Int., 2013, 233(1-3), e3-e5.
[66]
Sattout, A.H.; Nicol, M.F. Cardiac arrest following cannabis use: A case report. Cases J., 2009, 2, 208.
[67]
Scragg, R.K.; Mitchell, E.A.; Ford, R.P.; Thompson, J.M.; Taylor, B.J.; Stewart, A.W. Maternal cannabis use in the sudden death syndrome. Acta Paediatr., 2001, 90(1), 57-60.
[68]
Klonoff-Cohen, H.; Lam-Kruglick, P. Maternal and paternal recreational drug use and sudden infant death syndrome. Arch. Pediatr. Adolesc. Med., 2001, 155(7), 765-770.
[69]
Beaconsfield, P.; Ginsburg, J.; Rainsbury, R. Marihuana smoking: Cardiovascular effects in man and possible mechanisms. N. Engl. J. Med., 1972, 287(5), 209-212.
[70]
Jones, R.T. Cardiovascular system effects of marijuana. J. Clin. Pharmacol., 2002, 42(11)(Suppl.), 58s-63s.
[71]
Benowitz, N.L.; Jones, R.T. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin. Pharmacol. Ther., 1975, 18(3), 287-297.
[72]
Yankey, B.A.; Rothenberg, R.; Strasser, S.; Ramsey-White, K.; Okosun, I.S. Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the national health and nutrition examination survey linked mortality file. Eur. J. Prev. Cardiol., 2018, 24(17), 1833-1840.
[73]
Alshaarawy, O.; Elbaz, H.A. Cannabis use and blood pressure levels: United states national health and nutrition examination survey, 2005-2012. J. Hypertens., 2016, 34(8), 1507-1512.
[74]
Nowlan, R.; Cohen, S. Tolerance to marijuana: Heart rate and subjective “high”. Clin. Pharmacol. Ther., 1977, 22(5 Pt 1), 550-556.
[75]
Vandrey, R.; Umbricht, A.; Strain, E.C. Increased blood pressure after abrupt cessation of daily cannabis use. J. Addict. Med., 2011, 5(1), 16-20.
[76]
Barber, P.A.; Pridmore, H.M.; Krishnamurthy, V.; Roberts, S.; Spriggs, D.A.; Carter, K.N.; Anderson, N.E. Cannabis, ischemic stroke, and transient ischemic attack: A case-control study. Stroke, 2013, 44(8), 2327-2329.
[77]
Mateo, I.; Pinedo, A.; Gomez-Beldarrain, M.; Basterretxea, J.M.; Garcia-Monco, J.C. Recurrent stroke associated with cannabis use. J. Neurol. Neurosurg. Psychiatry, 2005, 76(3), 435-437.
[78]
Singh, N.N.; Pan, Y.; Muengtaweeponsa, S.; Geller, T.J.; Cruz-Flores, S. Cannabis-related stroke: Case series and review of literature. J. Stroke Cerebrovasc. Dis., 2012, 21(7), 555-560.
[79]
Moussouttas, M. Cannabis use and cerebrovascular disease. Neurologist, 2004, 10(1), 47-53.
[80]
Hackam, D.G. Cannabis and stroke: Systematic appraisal of case reports. Stroke, 2015, 46(3), 852-856.
[81]
Wolff, V.; Lauer, V.; Rouyer, O.; Sellal, F.; Meyer, N.; Raul, J.S.; Sabourdy, C.; Boujan, F.; Jahn, C.; Beaujeux, R.; Marescaux, C. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: A prospective study in 48 consecutive young patients. Stroke, 2011, 42(6), 1778-1780.
[82]
Wolff, V.; Armspach, J.P.; Beaujeux, R.; Manisor, M.; Rouyer, O.; Lauer, V.; Meyer, N.; Marescaux, C.; Geny, B. High frequency of intracranial arterial stenosis and cannabis use in ischaemic stroke in the young. Cerebrovasc. Dis., 2014, 37(6), 438-443.
[83]
Renard, D.; Taieb, G.; Gras-Combe, G.; Labauge, P. Cannabis-related myocardial infarction and cardioembolic stroke. J. Stroke Cerebrovasc. Dis., 2012, 21(1), 82-83.
[84]
Wolff, V.; Armspach, J.P.; Lauer, V.; Rouyer, O.; Bataillard, M.; Marescaux, C.; Geny, B. Cannabis-related stroke: Myth or reality? Stroke, 2013, 44(2), 558-563.
[85]
Wolff, V.; Jouanjus, E. Strokes are possible complications of cannabinoids use. Epilepsy Behav, 2017, 70(Pt B). , 355-363.
[86]
Disdier, P.; Granel, B.; Serratrice, J.; Constans, J.; Michon-Pasturel, U.; Hachulla, E.; Conri, C.; Devulder, B.; Swiader, L.; Piquet, P.; Branchereau, A.; Jouglard, J.; Moulin, G.; Weiller, P.J. Cannabis arteritis revisited-ten new case reports. Angiology, 2001, 52(1), 1-5.
[87]
Peyrot, I.; Garsaud, A.M.; Saint-Cyr, I.; Quitman, O.; Sanchez, B.; Quist, D. Cannabis arteritis: A new case report and a review of literature. J. Eur. Acad. Dermatol. Venereol., 2007, 21(3), 388-391.
[88]
Desbois, A.C.; Cacoub, P. Cannabis-associated arterial disease. Ann. Vasc. Surg., 2013, 27(7), 996-1005.
[89]
Rezkalla, S.; Stankowski, R.; Kloner, R.A. Cardiovascular effects of marijuana. J. Cardiovasc. Pharmacol. Ther., 2016, 21(5), 452-455.
[90]
Grotenhermen, F. Cannabis-associated arteritis. Vasa, 2010, 39(1), 43-53.
[91]
Santos, R.P.; Resende, C.I.; Vieira, A.P.; Brito, C. Cannabis arteritis: Ever more important to consider. BMJ Case Rep, 2017, 2017
[92]
Henry, J.A.; Oldfield, W.L.; Kon, O.M. Comparing cannabis with tobacco. BMJ, 2003, 326(7396), 942-943.
[93]
Meier, M.H.; Caspi, A.; Ambler, A.; Harrington, H.; Houts, R.; Keefe, R.S.; McDonald, K.; Ward, A.; Poulton, R.; Moffitt, T.E. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Natl. Acad. Sci. USA, 2012, 109(40), E2657-E2664.
[94]
Blakemore, S.J. Teenage kicks: Cannabis and the adolescent brain. Lancet, 2013, 381(9870), 888-889.
[95]
Stanley, C.; O’Sullivan, S.E. Vascular targets for cannabinoids: Animal and human studies. Br. J. Pharmacol., 2014, 171(6), 1361-1378.
[96]
Fairman, B.J.; Furr-Holden, C.D.; Johnson, R.M. When marijuana is used before cigarettes or alcohol: Demographic predictors and associations with heavy use, cannabis use disorder, and other drug-related outcomes. Prev. Sci., 2019, 20(2), 225-233.
[97]
Mokrysz, C.; Freeman, T.P.; Korkki, S.; Griffiths, K.; Curran, H.V. Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males. Transl. Psychiatry, 2016, 6(11)e961
[98]
Moir, D.; Rickert, W.S.; Levasseur, G.; Larose, Y.; Maertens, R.; White, P.; Desjardins, S. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem. Res. Toxicol., 2008, 21(2), 494-502.
[99]
Wang, X.; Derakhshandeh, R.; Liu, J.; Narayan, S.; Nabavizadeh, P.; Le, S.; Danforth, O.M.; Pinnamaneni, K.; Rodriguez, H.J.; Luu, E.; Sievers, R.E.; Schick, S.F.; Glantz, S.A.; Springer, M.L. One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function. J. Am. Heart Assoc., 2016, 5(8)e003858
[100]
Goodwin, R.D.; Cheslack-Postava, K.; Santoscoy, S.; Bakoyiannis, N.; Hasin, D.S.; Collins, B.N.; Lepore, S.J.; Wall, M.M. Trends in cannabis and cigarette use among parents with children at home: 2002 to 2015. Pediatrics, 2018, 14e20173506
[101]
Kennedy, M.C. Cannabis: Exercise performance and sport. A systematic review. J. Sci. Med. Sport, 2017, 20(9), 825-829.
[102]
Aronow, W.S.; Cassidy, J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N. Engl. J. Med., 1974, 291(2), 65-67.
[103]
Martinasek, M.P.; McGrogan, J.B.; Maysonet, A. A systematic review of the respiratory effects of inhalational marijuana. Respir. Care, 2016, 61(11), 1543-1551.
[104]
Biehl, J.R.; Burnham, E.L. Cannabis smoking in 2015: A concern for lung health? Chest, 2015, 148(3), 596-606.
[105]
Macleod, J.; Robertson, R.; Copeland, L.; McKenzie, J.; Elton, R.; Reid, P. Cannabis, tobacco smoking, and lung function: A cross-sectional observational study in a general practice population. Br. J. Gen. Pract., 2015, 65(631), e89-e95.
[106]
Imtiaz, S.; Shield, K.D.; Roerecke, M.; Cheng, J.; Popova, S.; Kurdyak, P.; Fischer, B.; Rehm, J. The burden of disease attributable to cannabis use in Canada in 2012. Addiction, 2016, 111(4), 653-662.
[107]
Fischer, B.; Imtiaz, S.; Rudzinski, K.; Rehm, J. Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities. J. Public Health (Oxf.), 2016, 38(1), 183-188.
[108]
Kilmer, B. Recreational cannabis - minimizing the health risks from legalization. N. Engl. J. Med., 2017, 376(8), 705-707.
[109]
Abouk, R.; Adams, S. Examining the relationship between medical cannabis laws and cardiovascular deaths in the US. Int. J. Drug Policy, 2018, 53, 1-7.
[110]
Singh, A.; Saluja, S.; Kumar, A.; Agrawal, S.; Thind, M.; Nanda, S.; Shirani, J. Cardiovascular complications of marijuana and related substances: A review. Cardiol. Ther., 2018, 7(1), 45-59.
